Evidence map›Paper›PMID 30073111›Full record

ArticleCase reports in urology2018

Lymphoepithelioma-Like Carcinoma of the Bladder: A Case Report of a Rare and Particular Variant of Urothelial Carcinoma.

Youness Jabbour, Youssef Jabri, Hamza Lamchahab, Mohammed Tbouda, Ahmed Jahid, Tarik Karmouni, Khalid El Khader, Abdellatif Koutani, Ahmed Iben Attya Andaloussi

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in urology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Bladder lymphoepithelioma-like carcinoma: a case report.Journal of surgical case reports · 2022
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Youness JabbourUrology B Department, Ibn Sina Teaching Hospital, Rabat, Morocco.ORCID 0000-0002-1921-2156
Youssef JabriUrology B Department, Ibn Sina Teaching Hospital, Rabat, Morocco.
Hamza LamchahabUrology B Department, Ibn Sina Teaching Hospital, Rabat, Morocco.
Mohammed TboudaFaculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
Ahmed JahidFaculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
Tarik KarmouniUrology B Department, Ibn Sina Teaching Hospital, Rabat, Morocco.
Khalid El KhaderUrology B Department, Ibn Sina Teaching Hospital, Rabat, Morocco.
Abdellatif KoutaniUrology B Department, Ibn Sina Teaching Hospital, Rabat, Morocco.
Ahmed Iben Attya AndaloussiUrology B Department, Ibn Sina Teaching Hospital, Rabat, Morocco.
Mohammed V University · MA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lymphoepithelioma-like carcinoma of the bladder (LELCB) is a rare variant of urothelial carcinoma first described by Zukerberg in 1991 and confirmed as a variant of urothelial carcinoma by the WHO classification of tumors of the urinary system. LELCB is characterized by a marked infiltration of lymphocytes in the area involved by the tumor which may coexist with the conventional urothelial carcinoma. LELCB are classified according to the percentage of lymphoepithelioma component within the tumor with the prognosis depending on the percentage. We report a new case of pure LELCB occurring in 63-year-old woman presenting with hematuria. Ultrasonography and cystoscopy revealed a large tumor on the left lateral wall of the bladder. Transurethral resection of the bladder tumor (TURBT) was performed. Pathological and immunohistochemical analysis revealed a high-grade muscle-invasive LELCB (G3pT2). The patient underwent an adjuvant systemic chemotherapy with no recurrence after a ten-month follow-up. To our knowledge, this is the second Moroccan case of LELCB reported in the English literature. Although its rare occurrence prognosis and ideal therapeutic management of LELCB have not been clearly established yet, literature findings encourage the adoption of a conservative approach in treatment of LELCB.

Identifiers

PMID30073111
PMCPMC6057318
OpenAlexW2857536349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.